These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1180 related items for PubMed ID: 17481774

  • 1. Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specificity.
    Akhtar S, Benter I.
    Adv Drug Deliv Rev; 2007 Mar 30; 59(2-3):164-82. PubMed ID: 17481774
    [Abstract] [Full Text] [Related]

  • 2. Cationic lipids and polymers mediated vectors for delivery of siRNA.
    Zhang S, Zhao B, Jiang H, Wang B, Ma B.
    J Control Release; 2007 Oct 18; 123(1):1-10. PubMed ID: 17716771
    [Abstract] [Full Text] [Related]

  • 3. RNA interference (RNAi) in hematology.
    Scherr M, Steinmann D, Eder M.
    Ann Hematol; 2004 Jan 18; 83(1):1-8. PubMed ID: 14574462
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA.
    Spagnou S, Miller AD, Keller M.
    Biochemistry; 2004 Oct 26; 43(42):13348-56. PubMed ID: 15491141
    [Abstract] [Full Text] [Related]

  • 6. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.
    Aigner A.
    J Biotechnol; 2006 Jun 25; 124(1):12-25. PubMed ID: 16413079
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. siRNAs: their potential as therapeutic agents--Part II. Methods of delivery.
    Singh SK, Hajeri PB.
    Drug Discov Today; 2009 Sep 25; 14(17-18):859-65. PubMed ID: 19540929
    [Abstract] [Full Text] [Related]

  • 9. Targeted delivery of siRNA by nonviral vectors: lessons learned from recent advances.
    Li SD, Huang L.
    Curr Opin Investig Drugs; 2008 Dec 25; 9(12):1317-23. PubMed ID: 19037838
    [Abstract] [Full Text] [Related]

  • 10. Cationic nanosystems for the delivery of small interfering ribonucleic acid therapeutics: a focus on toxicogenomics.
    Akhtar S.
    Expert Opin Drug Metab Toxicol; 2010 Nov 25; 6(11):1347-62. PubMed ID: 20929276
    [Abstract] [Full Text] [Related]

  • 11. Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors.
    Sun Y, Li Z, Li L, Li J, Liu X, Li W.
    Int J Mol Med; 2007 Apr 25; 19(4):705-11. PubMed ID: 17334648
    [Abstract] [Full Text] [Related]

  • 12. Selection and validation of optimal siRNA target sites for RNAi-mediated gene silencing.
    Luo Q, Kang Q, Song WX, Luu HH, Luo X, An N, Luo J, Deng ZL, Jiang W, Yin H, Chen J, Sharff KA, Tang N, Bennett E, Haydon RC, He TC.
    Gene; 2007 Jun 15; 395(1-2):160-9. PubMed ID: 17449199
    [Abstract] [Full Text] [Related]

  • 13. HIV-1-specific RNA interference.
    Boden D, Pusch O, Ramratnam B.
    Curr Opin Mol Ther; 2004 Aug 15; 6(4):373-80. PubMed ID: 15468596
    [Abstract] [Full Text] [Related]

  • 14. Efficient and targeted delivery of siRNA in vivo.
    Shim MS, Kwon YJ.
    FEBS J; 2010 Dec 15; 277(23):4814-27. PubMed ID: 21078116
    [Abstract] [Full Text] [Related]

  • 15. A peptidomimetic siRNA transfection reagent for highly effective gene silencing.
    Utku Y, Dehan E, Ouerfelli O, Piano F, Zuckermann RN, Pagano M, Kirshenbaum K.
    Mol Biosyst; 2006 Jun 15; 2(6-7):312-7. PubMed ID: 16880950
    [Abstract] [Full Text] [Related]

  • 16. Oral delivery of siRNA and antisense oligonucleotides.
    Akhtar S.
    J Drug Target; 2009 Aug 15; 17(7):491-5. PubMed ID: 19530907
    [Abstract] [Full Text] [Related]

  • 17. A tightly regulated and reversibly inducible siRNA expression system for conditional RNAi-mediated gene silencing in mammalian cells.
    Wu RH, Cheng TL, Lo SR, Hsu HC, Hung CF, Teng CF, Wu MP, Tsai WH, Chang WT.
    J Gene Med; 2007 Jul 15; 9(7):620-34. PubMed ID: 17486668
    [Abstract] [Full Text] [Related]

  • 18. Sequence-specific gene silencing in murine muscle induced by electroporation-mediated transfer of short interfering RNA.
    Kishida T, Asada H, Gojo S, Ohashi S, Shin-Ya M, Yasutomi K, Terauchi R, Takahashi KA, Kubo T, Imanishi J, Mazda O.
    J Gene Med; 2004 Jan 15; 6(1):105-10. PubMed ID: 14716682
    [Abstract] [Full Text] [Related]

  • 19. Lipid-mediated siRNA delivery down-regulates exogenous gene expression in the mouse brain at picomolar levels.
    Hassani Z, Lemkine GF, Erbacher P, Palmier K, Alfama G, Giovannangeli C, Behr JP, Demeneix BA.
    J Gene Med; 2005 Feb 15; 7(2):198-207. PubMed ID: 15515135
    [Abstract] [Full Text] [Related]

  • 20. Using RNAi in the clinic.
    Dev KK.
    IDrugs; 2006 Apr 15; 9(4):279-82. PubMed ID: 16596482
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.